(EMIS) BNP Paribas Easy MSCI - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU1659681230 • Global Emerging Markets Equity

EMIS: Stocks, Bonds, Emerging Markets, Sustainability, ETF

BNP Paribas Easy MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF EUR Capitalisation (Ticker: EMIS) is a UCITS-compliant ETF listed on Euronext Paris. It tracks the Morningstar EM TME NR USD index, which focuses on emerging markets equities with an emphasis on ESG (Environmental, Social, and Governance) criteria. The fund employs a capped investment strategy, ensuring no single holding exceeds 5% of the funds assets. The ETF is designed for investors seeking exposure to emerging markets while aligning with sustainable investment principles.

From a technical perspective, EMIS has shown a price of 13.11 EUR as of the latest close, with a 20-day average volume of 13,310 shares. The ETFs short-term trend indicators, such as the 20-day SMA (13.64) and 50-day SMA (13.54), currently stand above the last price, signaling potential bearish momentum. The 200-day SMA (13.35) is slightly below the current price, indicating a neutral long-term outlook. Volatility remains subdued, with an ATR of 0.13, suggesting limited price fluctuations in recent trading sessions.

From a fundamental standpoint, the ETF manages assets under management (AUM) of 99.09 million EUR, reflecting moderate scale and liquidity. The funds focus on ESG criteria aligns with growing investor demand for sustainable investment products. Emerging markets, in general, are expected to benefit from long-term structural growth trends, though near-term performance may be influenced by macroeconomic factors such as interest rates, commodity prices, and geopolitical developments.

3-Month Forecast: Based on and , EMIS is expected to trade within a narrow range of 12.90 to 13.70 EUR over the next three months. The ETFs price movement will likely be influenced by its technical resistance levels (SMA 50: 13.54) and support levels (SMA 200: 13.35). On the fundamental side, continued inflows into ESG-focused products and stability in emerging markets could provide upside potential, while global macroeconomic uncertainties may act as a headwind.

Additional Sources for EMIS ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EMIS ETF Overview

Market Cap in USD 107m
Category Global Emerging Markets Equity
TER 0.31%
IPO / Inception 2018-07-06

EMIS ETF Ratings

Growth 5y 39.2%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -4.9
Analysts -
Fair Price Momentum 11.89 EUR
Fair Price DCF -

EMIS Dividends

No Dividends Paid

EMIS Growth Ratios

Growth Correlation 3m -18.6%
Growth Correlation 12m 73%
Growth Correlation 5y 9.7%
CAGR 5y 9.24%
CAGR/Max DD 5y 0.47
Sharpe Ratio 12m -0.21
Alpha -4.38
Beta 0.56
Volatility 16.26%
Current Volume 1.6k
Average Volume 20d 3.2k
What is the price of EMIS stocks?
As of March 15, 2025, the stock is trading at EUR 13.06 with a total of 1,554 shares traded.
Over the past week, the price has changed by -0.02%, over one month by -4.63%, over three months by -4.89% and over the past year by +3.03%.
Is BNP Paribas Easy MSCI a good stock to buy?
Partly, yes. Based on ValueRay Analyses, BNP Paribas Easy MSCI (PA:EMIS) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.19 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMIS as of March 2025 is 11.89. This means that EMIS is currently overvalued and has a potential downside of -8.96%.
Is EMIS a buy, sell or hold?
BNP Paribas Easy MSCI has no consensus analysts rating.
What are the forecast for EMIS stock price target?
According to ValueRays Forecast Model, EMIS BNP Paribas Easy MSCI will be worth about 13.2 in March 2026. The stock is currently trading at 13.06. This means that the stock has a potential upside of +1.07%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 13.2 1.1%